Cannabinoid Receptor 1 Blockade Attenuates Obesity and Adipose Tissue Type 1 Inflammation Through miR-30e-5p Regulation of Delta-Like-4 in Macrophages and Consequently Downregulation of Th1 Cells

Obesity is characterized by chronic low-grade inflammation that contributes to development of cardiometabolic disorders. Cannabinoid receptor 1 (CB1) antagonists attenuate diet-induced obesity (DIO) and related inflammation, although the precise anti-inflammatory mechanisms involved have not been fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Miranda, Kathryn, Mehrpouya-Bahrami, Pegah, Nagarkatti, Prakash S., Nagarkatti, Mitzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523050/
https://www.ncbi.nlm.nih.gov/pubmed/31134094
http://dx.doi.org/10.3389/fimmu.2019.01049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523050/
https://www.ncbi.nlm.nih.gov/pubmed/31134094
http://dx.doi.org/10.3389/fimmu.2019.01049

Ejemplares similares